Search Results - "Ohara, Yuuki"
-
1
Drug-exposed cancer-associated fibroblasts facilitate gastric cancer cell progression following chemotherapy
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01-07-2021)“…Background Cancer progression following chemotherapy is a significant barrier to effective cancer treatment. We aimed to evaluate the role of drug-exposed…”
Get full text
Journal Article -
2
Phlebotomy as a preventive measure for crocidolite‐induced mesothelioma in male rats
Published in Cancer science (01-02-2018)“…Malignant mesothelioma (MM) is a rare but socially important neoplasm due to its association with asbestos exposure. Malignant mesothelioma is difficult to…”
Get full text
Journal Article -
3
Non-thermal plasma specifically kills oral squamous cell carcinoma cells in a catalytic Fe(II)-dependent manner
Published in Journal of Clinical Biochemistry and Nutrition (01-01-2019)“…Oral cancer accounts for ~2% of all cancers worldwide, and therapeutic intervention is closely associated with quality of life. Here, we evaluated the effects…”
Get full text
Journal Article -
4
SERPINB3-MYC axis induces the basal-like/squamous subtype and enhances disease progression in pancreatic cancer
Published in Cell reports (Cambridge) (26-12-2023)“…Pancreatic ductal adenocarcinoma (PDAC) exhibits distinct molecular subtypes: classical/progenitor and basal-like/squamous. Our study aimed to identify genes…”
Get full text
Journal Article -
5
Dual preventive benefits of iron elimination by desferal in asbestos‐induced mesothelial carcinogenesis
Published in Cancer science (01-07-2016)“…Asbestos‐induced mesothelial carcinogenesis is currently a profound social issue due to its extremely long incubation period and high mortality rate…”
Get full text
Journal Article -
6
Connective tissue growth factor-specific monoclonal antibody inhibits growth of malignant mesothelioma in an orthotopic mouse model
Published in Oncotarget (06-04-2018)“…Malignant mesothelioma is an aggressive neoplasm with no particularly effective treatments. We previously reported that overexpression of connective tissue…”
Get full text
Journal Article -
7
Osteogenic differentiation in dedifferentiated liposarcoma: a study of 36 cases in comparison to the cases without ossification
Published in Histopathology (01-04-2018)“…Aims Ossification is found occasionally in dedifferentiated liposarcoma (DDLPS). The aims of this study were to elucidate whether the formed bone tissue is…”
Get full text
Journal Article -
8
An autopsy case report: Differences in radiological images correlate with histology in Erdheim–Chester disease
Published in Pathology international (01-06-2018)“…p16 activation caused by oncogenic mutations may represent oncogene‐induced senescence (OIS), a protective mechanism against oncogenic events. However, OIS can…”
Get full text
Journal Article -
9
Acute fulminant invasive pulmonary aspergillosis in an immunocompetent host: An autopsy case report
Published in Medical mycology case reports (01-06-2018)“…A 62-year-old previously healthy male who was a welder/smoker/drinker was admitted to Kani Tono Hospital for severe hypoxemia (Day 0). Initial physical and…”
Get full text
Journal Article -
10
Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments
Published in Cancer cell (14-02-2022)“…The balance of programmed death-1 (PD-1)-expressing CD8+ T cells and regulatory T (Treg) cells in the tumor microenvironment (TME) determines the clinical…”
Get full text
Journal Article -
11
The interactive role of inflammatory mediators and metabolic reprogramming in pancreatic cancer
Published in Trends in cancer (01-07-2022)“…Pancreatic ductal adenocarcinoma (PDAC) is characterized by its highly reactive inflammatory desmoplastic stroma with evidence of an extensive tumor stromal…”
Get more information
Journal Article -
12
The critical role of CD4+ T cells in PD-1 blockade against MHC-II–expressing tumors such as classic Hodgkin lymphoma
Published in Blood advances (08-09-2020)“…Classic Hodgkin lymphoma (cHL) responds markedly to PD-1 blockade therapy, and the clinical responses are reportedly dependent on expression of major…”
Get full text
Journal Article -
13
LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism
Published in Carcinogenesis (New York) (08-07-2024)“…Pancreatic ductal adenocarcinoma (PDAC) encompasses diverse molecular subtypes, including the classical/progenitor and basal-like/squamous subtypes, each…”
Get full text
Journal Article -
14
ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancer
Published in International journal of cancer (01-08-2024)“…Pancreatic ductal adenocarcinoma (PDAC) is a heterogeneous disease with distinct molecular subtypes described as classical/progenitor and basal-like/squamous…”
Get full text
Journal Article -
15
ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer
Published in Carcinogenesis (New York) (13-08-2024)“…Pancreatic ductal adenocarcinoma (PDAC) manifests diverse molecular subtypes, including the classical/progenitor and basal-like/squamous subtypes, with the…”
Get full text
Journal Article -
16
MIF/NR3C2 axis regulates glucose metabolism reprogramming in pancreatic cancer through MAPK–ERK and AP-1 pathways
Published in Carcinogenesis (New York) (12-08-2024)“…Abstract Inflammation and aberrant cellular metabolism are widely recognized as hallmarks of cancer. In pancreatic ductal adenocarcinoma (PDAC), inflammatory…”
Get full text
Journal Article -
17
Dysregulation of HNF1B/Clusterin axis enhances disease progression in a highly aggressive subset of pancreatic cancer patients
Published in Carcinogenesis (New York) (31-12-2022)“…Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy and is largely refractory to available treatments. Identifying key pathways associated with…”
Get full text
Journal Article -
18
291 - Preclinical Use of CTGF-Specific Monoclonal Antibody for the Treatment of Malignant Mesothelioma
Published in Free radical biology & medicine (01-11-2016)“…Malignant mesothelioma (MM) is a tumor mostly caused by asbestos exposure. There are several theories of carcinogenesis, including oxidative stress theory…”
Get full text
Journal Article -
19
Preclinical Use of CTGF-Specific Monoclonal Antibody for the Treatment of Malignant Mesothelioma
Published in Free radical biology & medicine (01-11-2016)Get full text
Journal Article -
20
Connective tissue growth factor produced by cancer‑associated fibroblasts correlates with poor prognosis in epithelioid malignant pleural mesothelioma
Published in Oncology reports (01-09-2020)“…Malignant mesothelioma is an aggressive neoplasm for which effective treatments are lacking. We often encounter mesothelioma cases with a profound desmoplastic…”
Get full text
Journal Article